Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach

Recently, the development of targeted therapy approaches such as those based on tyrosine kinase inhibitor (TKI) greatly improved the clinical outcomes of patients affected by oncogene addicted advanced non-small cell lung cancer (NSCLC). Similarly, the improvement of radiation therapy techniques has...

Повний опис

Бібліографічні деталі

Автори:	Francesca Di Pressa, Fabiana Perrone, Anna Benini, Frank Lohr, Marcello Tiseo, Alessio Bruni
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Open Exploration Publishing Inc. 2024-05-01
Серія:	Exploration of Targeted Anti-tumor Therapy
Предмети:	non-small cell lung cancer radiotherapy target therapy epidermal growth factor receptor mutation tyrosine kinase inhibitor oligometastatic oligoprogression
Онлайн доступ:	https://www.explorationpub.com/Journals/etat/Article/1002228
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!